Use of cyclopamine in the treatment of psoriasis and other skin disorders
CA 2481499 C · Owner: Tas, Sinan · Inventors: Tas, Sinan; Avci, Oktay
Overview
Its claims, description and drawings are in the Canadian Patents Database.
Open the CIPO recordAbstract From the Canadian patent
Pharmaceutical compositions containing cyclopamine enable the skin cells displaying inhibited cellular differentiation to overcome that inhibition. Such compositions are effective in treatment of diseases associated with impaired cellular differentiation. In tumors induction of the differentiation , of tumor cells by cyclopamine is accompanied commonly by the apoptosis of tumor cells, adding thereby to the therapeutic effectiveness. Effectiveness of cyclopamine in the treatment of psoriasis a common disease associated with , the impairment of cellular differentiation is enhanced significantly by using compositions comprising of cyclopamine and a corticosteroid
Read the whole patent
Listed from its CIPO record in Patent Yard's archive of Canadian patents past their term. Its claims, description and drawings are in the CIPO record and on Google Patents, and the Claude kit works from them.
Why it's free to use
- Filed March 17, 2003 and granted May 21, 2013. A Canadian patent filed from October 1, 1989 lasts 20 years from filing, so its term ended March 17, 2023.
- A certificate of supplementary protection adds at most two years for a drug, so even that would have ended by March 17, 2025.
- We check Canadian rights only. A patent in its family in another country could still be in force: check its family on Google Patents.
Timeline
Timeline From CIPO dates
Sources & verification
Official CIPO records
Everything on this page comes from the CIPO record linked above. Contains information licensed under the Open Government Licence – Canada.